Morgan Stanley
PHAR

Morgan Stanley’s Pharming Group PHAR Stock Holding History

Morgan Stanley’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Buy
11,500
+11
+0.1% +$159 ﹤0.01% 6055
2026
Q1 		$191K Buy
11,489
+3,789
+49% +$64.2K ﹤0.01% 5894
2025
Q4 		$136K Buy
7,700
+3,345
+77% +$52.6K ﹤0.01% 6076
2025
Q3 		$63.1K Buy
4,355
+1,455
+50% +$18.1K ﹤0.01% 6323
2025
Q2 		$31K Hold
2,900
– – ﹤0.01% 6509
2025
Q1 		$24.3K Buy
2,900
+300
+12% +$2.69K ﹤0.01% 6502
2024
Q4 		$26.2K Sell
2,600
-700
-21% -$5.96K ﹤0.01% 6493
2024
Q3 		$27.2K Buy
3,300
+500
+18% +$3.96K ﹤0.01% 6403
2024
Q2 		$23.4K Hold
2,800
– – ﹤0.01% 6408
2024
Q1 		$29.4K Hold
2,800
– – ﹤0.01% 6376
2023
Q4 		$32K Buy
2,800
+300
+12% +$3.44K ﹤0.01% 6307
2023
Q3 		$28.5K Hold
2,500
– – ﹤0.01% 6371
2023
Q2 		$29.1K Hold
2,500
– – ﹤0.01% 6426
2023
Q1 		$33.8K Sell
2,500
-4,149
-62% -$52.4K ﹤0.01% 6426
2022
Q4 		$73.3K Sell
6,649
-101
-1% -$1.12K ﹤0.01% 6117
2022
Q3 		$66K Buy
6,750
+4,250
+170% +$42.9K ﹤0.01% 6277
2022
Q2 		$22K Hold
2,500
– – ﹤0.01% 6938
2022
Q1 		$22K Hold
2,500
– – ﹤0.01% 7109
2021
Q4 		$22K Sell
2,500
-48
-2% -$425 ﹤0.01% 7186
2021
Q3 		$24K Hold
2,548
– – ﹤0.01% 7035
2021
Q2 		$29K Buy
2,548
+2,500
+5,208% +$31.1K ﹤0.01% 6875
2021
Q1 		$1K Buy
+48
New +$669 ﹤0.01% 7366

Other funds holding PHAR

MACM
MAC Alpha Capital Management Tampa, Florida $216M AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley's PHAR Position: Q2 2026 in Review

Morgan Stanley increased its Pharming Group (PHAR) stake by 0.1% in Q2 2026, buying an estimated $159 and bringing the position to 11,500 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #6055.

Morgan Stanley first reported a position in PHAR in Q1 2021 and has held it in 22 quarters since. The position peaked at $191K in Q1 2026. 17 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • Morgan Stanley held 11,500 shares of Pharming Group worth $160K as of Q2 2026.
  • Morgan Stanley bought 11 Pharming Group shares in Q2 2026, an estimated $159.
  • Pharming Group made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6055 holding.
  • Morgan Stanley first reported a position in Pharming Group in Q1 2021 and has held it in 22 quarters since.
  • Morgan Stanley's Pharming Group position peaked at $191K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.